Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus

• Váldodahkkit: Yi Cheng (Dahkki), Dongbei Sheng (Dahkki), Xiangdong Li (Dahkki), Sumei Hong (Dahkki), Lixia Guo (Dahkki), Shasha Zhao (Dahkki), Yue Yuan (Dahkki), Jingjing Xue (Dahkki), Hui Tian (Dahkki), Yipin Ren (Dahkki), Wujie Liu (Dahkki), Kegong Tian (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Journal of Vaccines and Immunology - Peertechz Publications, 2016-10-25.
• Fáttát: Research Article
• Liŋkkat: Connect to this object online.

<p><strong>Background:</strong> Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating and vaccine strains of viruses may compromi...